Stock Earnings

Question 1

What are Vertex Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Vertex Pharmaceuticals Inc has a total asset of $25,643, Net profit of $3,953

Question 2

What are the key financial ratios for VRTX?

Accepted Answer

Vertex Pharmaceuticals Inc's Current ratio is 3.67, has a Net margin is 32.93, sales per share of $46.51.

Question 3

How is Vertex Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Vertex Pharmaceuticals Inc largest revenue segment is Other, at a revenue of 644,700,000 in the most earnings release.For geography, Other Collaborative and Royalty is the primary market for Vertex Pharmaceuticals Inc, at a revenue of 30,700,000.

Question 4

Is Vertex Pharmaceuticals Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Vertex Pharmaceuticals Inc has a net profit of $3,953

Question 5

Does Vertex Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Vertex Pharmaceuticals Inc has liability of 6,977

Question 6

How many outstanding shares for Vertex Pharmaceuticals Inc?

Accepted Answer

Vertex Pharmaceuticals Inc has a total outstanding shares of 253.99

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	12,218	12,001	11,020	9,869	8,930	7,574
Revenue Growth (YoY)	10%	9%	12%	11%	18%	22%
Cost of Revenue	1,681	1,651	1,530	1,262	1,080	904
Gross Profit	10,536	10,350	9,489	8,607	7,850	6,670
Selling, General & Admin	1,850	1,753	1,464	1,136	944	840
Research & Development	3,891	3,909	3,630	3,162	2,527	3,051
Operating Expenses	5,741	5,664	5,094	4,247	3,414	3,888
Other Non Operating Income (Expenses)	-2	3	-76	-15	-15	-12
Pretax Income	5,165	4,643	248	4,379	4,232	2,730
Income Tax Expense	827	690	784	760	910	388
Net Income	4,338	3,953	-535	3,619	3,322	2,342
Net Income Growth	-539%	-839%	-114.99%	9%	42%	-14%
Shares Outstanding (Diluted)	256.3	258	257.9	260.5	259.1	259.9
Shares Change (YoY)	-1%	0%	-1%	1%	0%	-1%
EPS (Diluted)	16.92	15.32	-2.08	13.89	12.82	9.01
EPS Growth	-544%	-836.99%	-114.99%	8%	42%	-12%
Free Cash Flow	3,710	3,193	-978	3,278	3,925	2,408
Free Cash Flow Per Share	14.47	12.37	-3.79	12.58	15.14	9.26
Gross Margin	86.23%	86.24%	86.1%	87.21%	87.9%	88.06%
Operating Margin	39.24%	39.03%	39.88%	44.16%	49.66%	36.73%
Profit Margin	35.5%	32.93%	-4.85%	36.67%	37.2%	30.92%
Free Cash Flow Margin	30.36%	26.6%	-8.87%	33.21%	43.95%	31.79%
EBITDA	5,012	4,894	4,602	4,540	4,583	2,907
EBITDA Margin	41.02%	40.77%	41.76%	46%	51.32%	38.38%
D&A For EBITDA	217	209	207	181	148	125
EBIT	4,795	4,685	4,395	4,359	4,435	2,782
EBIT Margin	39.24%	39.03%	39.88%	44.16%	49.66%	36.73%
Effective Tax Rate	16.01%	14.86%	316.12%	17.35%	21.5%	14.21%

Vertex Pharmaceuticals Inc (VRTX) Price

VRTX Stock Price Chart

VRTX Income

Follow-Up Questions